because 2001, the extension has become restricted to publish-secondary institutions accredited by an agency on a certain list. What this means is institutions do rarely use it outside of the U.S. What else are these higher performers performing otherwise? For one thing, They are really paying far more interest to gen-AI-associated risks. Potential